RXL

Ultra Health Care

Investment Objective

ProShares Ultra Health Care seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index.

Performance

Daily Return during Q1 2022
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
RXL NAV -7.23% -9.75% 8.84% 27.13% 36.52% 20.01% 26.75% 29.99% 18.38% 01/30/2007
RXL Market Price -7.42% -9.73% 8.66% 27.14% 36.69% 20.01% 26.67% 29.99% 18.37% 01/30/2007

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker RXL
  • Intraday Ticker RXL.IV
  • CUSIP 74347R735
  • Inception Date 1/30/07
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.04%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 1/14/2022
  • NAV $99.54
  • NAV Change -$0.31 down caret
  • Market Price $99.51
  • Market Price Change -$0.20 down caret
  • Trading Volume (M) 7,823
  • 30-Day Median Bid Ask Spread 0.14%
  • View Premium / Discount
Snapshot
  • Ticker RXL
  • Intraday Ticker RXL.IV
  • CUSIP 74347R735
  • Inception Date 1/30/07
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.04%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 1/14/2022
  • NAV $99.54
  • NAV Change -$0.31 down caret
  • Market Price $99.51
  • Market Price Change -$0.20 down caret
  • Trading Volume (M) 7,823
  • 30-Day Median Bid Ask Spread 0.14%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/22.

Exposures

Index as of 9/30/2021

Holdings

as of 1/14/2022

Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts
11.35% -- NET OTHER ASSETS / CASH -- $17,790,802.62 17,790,803
7.08% JNJ JOHNSON & JOHNSON -- $11,094,727.52 66,103
7.07% UNH UNITEDHEALTH GROUP INC -- $11,084,518.50 23,650
4.94% PFE PFIZER INC -- $7,744,762.90 140,942
3.85% ABBV ABBVIE INC -- $6,031,676.91 44,393
3.75% TMO THERMO FISHER SCIENTIFIC INC -- $5,884,951.20 9,894
3.63% ABT ABBOTT LABORATORIES -- $5,690,560.32 44,402
3.29% MRK MERCK & CO. INC. -- $5,162,340.30 63,435
3.10% LLY ELI LILLY & CO -- $4,867,020.44 19,937
2.99% DHR DANAHER CORP -- $4,683,867.39 15,969
2.34% -- MEDTRONIC PLC -- $3,668,447.25 33,795
2.31% BMY BRISTOL-MYERS SQUIBB CO -- $3,619,068.34 55,738
2.25% CVS CVS HEALTH CORP -- $3,521,086.78 33,149
2.12% AMGN AMGEN INC -- $3,328,696.48 14,143
1.76% ISRG INTUITIVE SURGICAL INC -- $2,758,581.36 8,964
1.76% ANTM ANTHEM INC -- $2,754,889.02 6,093
1.56% ZTS ZOETIS INC -- $2,449,418.40 11,880
1.44% GILD GILEAD SCIENCES INC -- $2,260,611.46 31,498
1.43% SYK STRYKER CORP -- $2,248,632.01 8,431
1.29% CI CIGNA CORP -- $2,015,580.91 8,323
1.21% BDX BECTON DICKINSON AND CO -- $1,893,752.82 7,211
1.18% EW EDWARDS LIFESCIENCES CORP -- $1,854,080.28 15,678
1.16% MRNA MODERNA INC -- $1,813,498.34 8,858
1.04% REGN REGENERON PHARMACEUTICALS -- $1,632,231.72 2,653
1.02% BSX BOSTON SCIENTIFIC CORP -- $1,605,270.24 35,784
1.01% ILMN ILLUMINA INC -- $1,590,174.50 3,925
0.99% HCA HCA HEALTHCARE INC -- $1,545,598.00 6,014
0.95% VRTX VERTEX PHARMACEUTICALS INC -- $1,494,473.10 6,385
0.81% HUM HUMANA INC -- $1,263,886.82 3,227
0.76% IQV IQVIA HOLDINGS INC -- $1,186,489.98 4,797
0.75% CNC CENTENE CORP -- $1,180,299.15 14,653
0.72% IDXX IDEXX LABORATORIES INC -- $1,127,515.50 2,130
0.70% A AGILENT TECHNOLOGIES INC -- $1,099,568.00 7,600
0.69% DXCM DEXCOM INC -- $1,088,378.22 2,433
0.69% BAX BAXTER INTERNATIONAL INC -- $1,078,009.02 12,573
0.63% MCK MCKESSON CORP -- $983,241.16 3,833
0.62% ALGN ALIGN TECHNOLOGY INC -- $965,843.83 1,841
0.59% RMD RESMED INC -- $922,653.44 3,659
0.56% BIIB BIOGEN INC -- $882,777.70 3,689
0.56% MTD METTLER-TOLEDO INTERNATIONAL -- $874,375.28 578
0.45% WST WEST PHARMACEUTICAL SERVICES -- $706,770.58 1,861
0.43% ZBH ZIMMER BIOMET HOLDINGS INC -- $668,362.86 5,247
0.42% LH LABORATORY CRP OF AMER HLDGS -- $663,696.32 2,404
0.38% STE STERIS PLC -- $589,114.24 2,512
0.37% AVTR AVANTOR INC -- $576,925.29 15,299
0.33% HZNP HORIZON THERAPEUTICS PLC -- $518,905.60 5,696
0.33% WAT WATERS CORP -- $511,941.82 1,534
0.32% COO COOPER COS INC/THE -- $508,223.76 1,238
0.30% CTLT CATALENT INC -- $465,323.76 4,299
0.29% VTRS VIATRIS INC -- $462,231.40 30,370
0.29% SGEN SEAGEN INC -- $459,388.59 3,351
0.29% CRL CHARLES RIVER LABORATORIES -- $450,152.68 1,268
0.28% ALNY ALNYLAM PHARMACEUTICALS INC -- $446,094.00 3,004
0.28% HOLX HOLOGIC INC -- $442,870.76 6,364
0.28% DGX QUEST DIAGNOSTICS INC -- $438,141.70 3,079
0.27% PODD INSULET CORP -- $420,131.01 1,731
0.27% MOH MOLINA HEALTHCARE INC -- $419,422.60 1,466
0.27% BMRN BIOMARIN PHARMACEUTICAL INC -- $416,004.42 4,611
0.25% TECH BIO-TECHNE CORP -- $384,258.35 985
0.24% TFX TELEFLEX INC -- $383,407.75 1,177
0.23% RPRX ROYALTY PHARMA PLC- CL A -- $354,957.00 8,950
0.23% INCY INCYTE CORP -- $352,909.44 4,713
0.22% ABMD ABIOMED INC -- $343,993.24 1,142
0.22% BIO BIO-RAD LABORATORIES-A -- $340,500.66 542
0.22% EXAS EXACT SCIENCES CORP -- $339,366.61 4,327
0.20% ELAN ELANCO ANIMAL HEALTH INC -- $321,143.43 11,881
0.20% TDOC TELADOC HEALTH INC -- $319,950.97 4,021
0.19% MASI MASIMO CORP -- $297,410.08 1,276
0.19% XRAY DENTSPLY SIRONA INC -- $296,076.66 5,489
0.17% HSIC HENRY SCHEIN INC -- $270,907.74 3,483
0.16% RGEN REPLIGEN CORP -- $249,498.66 1,291
0.16% UHS UNIVERSAL HEALTH SERVICES-B -- $245,418.12 1,836
0.15% UTHR UNITED THERAPEUTICS CORP -- $241,774.80 1,130
0.15% TXG 10X GENOMICS INC-CLASS A -- $239,200.00 2,300
0.15% SYNH SYNEOS HEALTH INC -- $234,243.97 2,603
0.14% JAZZ JAZZ PHARMACEUTICALS PLC -- $222,799.20 1,544
0.14% THC TENET HEALTHCARE CORP -- $217,997.60 2,690
0.13% NVAX NOVAVAX INC -- $210,336.36 1,898
0.13% PEN PENUMBRA INC -- $209,307.98 881
0.13% OGN ORGANON & CO -- $209,186.76 6,366
0.13% GH GUARDANT HEALTH INC -- $197,906.58 2,551
0.12% TNDM TANDEM DIABETES CARE INC -- $192,853.72 1,597
0.12% DVA DAVITA INC -- $190,299.52 1,636
0.12% -- ENVISTA HOLDINGS CORP -- $187,648.12 4,052
0.12% CHE CHEMED CORP -- $187,410.72 386
0.12% NBIX NEUROCRINE BIOSCIENCES INC -- $186,653.52 2,382
0.12% BRKR BRUKER CORP -- $180,336.00 2,550
0.11% BHVN BIOHAVEN PHARMACEUTICAL HOLD -- $178,734.71 1,463
0.10% EHC ENCOMPASS HEALTH CORP -- $164,452.42 2,497
0.10% NTLA INTELLIA THERAPEUTICS INC -- $158,709.69 1,737
0.10% SRPT SAREPTA THERAPEUTICS INC -- $155,566.80 2,188
0.10% NVCR NOVOCURE LTD -- $155,036.16 2,243
0.10% MRTX MIRATI THERAPEUTICS INC -- $154,641.64 1,244
0.10% ARWR ARROWHEAD PHARMACEUTICALS IN -- $151,404.39 2,619
0.09% NTRA NATERA INC -- $148,820.33 2,209
0.09% SWAV SHOCKWAVE MEDICAL INC -- $147,777.30 885
0.09% GMED GLOBUS MEDICAL INC - A -- $145,798.25 1,985
0.09% EXEL EXELIXIS INC -- $143,981.52 7,946
0.09% PRGO PERRIGO CO PLC -- $133,453.07 3,359
0.08% ACHC ACADIA HEALTHCARE CO INC -- $130,128.54 2,258
0.08% MEDP MEDPACE HOLDINGS INC -- $127,292.55 721
0.08% IART INTEGRA LIFESCIENCES HOLDING -- $125,816.91 1,829
0.08% HALO HALOZYME THERAPEUTICS INC -- $125,775.72 3,537
0.08% RARE ULTRAGENYX PHARMACEUTICAL IN -- $123,421.65 1,713
0.08% PINC PREMIER INC-CLASS A -- $121,184.99 3,061
0.08% AMED AMEDISYS INC -- $120,074.22 818
0.07% IONS IONIS PHARMACEUTICALS INC -- $117,334.76 3,547
0.07% BPMC BLUEPRINT MEDICINES CORP -- $115,128.00 1,476
0.07% ICUI ICU MEDICAL INC -- $109,995.00 500
0.07% QDEL QUIDEL CORP -- $109,480.64 953
0.07% NEOG NEOGEN CORP -- $105,084.00 2,700
0.07% HQY HEALTHEQUITY INC -- $104,724.18 2,097
0.07% LHCG LHC GROUP INC -- $104,610.32 796
0.07% ALKS ALKERMES PLC -- $102,565.50 4,062
0.06% STAA STAAR SURGICAL CO -- $90,063.42 1,194
0.06% FATE FATE THERAPEUTICS INC -- $87,944.96 2,032
0.05% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $83,104.20 2,740
0.05% DNLI DENALI THERAPEUTICS INC -- $81,212.04 2,331
0.05% OSH OAK STREET HEALTH INC -- $77,308.00 3,514
0.05% NEO NEOGENOMICS INC -- $77,164.36 3,094
0.05% BEAM BEAM THERAPEUTICS INC -- $76,433.14 1,127
0.05% TWST TWIST BIOSCIENCE CORP -- $74,057.16 1,238
0.05% NUVA NUVASIVE INC -- $72,821.94 1,299
0.05% VIR VIR BIOTECHNOLOGY INC -- $71,246.70 1,841
0.04% PACB PACIFIC BIOSCIENCES OF CALIF -- $68,576.31 5,517
0.04% ACAD ACADIA PHARMACEUTICALS INC -- $67,951.40 2,948
0.04% HAE HAEMONETICS CORP/MASS -- $67,653.96 1,284
0.04% RCM R1 RCM INC -- $67,341.64 3,347
0.04% EBS EMERGENT BIOSOLUTIONS INC -- $62,768.44 1,202
0.04% NVTA INVITAE CORP -- $61,306.28 5,222
0.04% DOCS DOXIMITY INC-CLASS A -- $56,340.72 1,224
0.04% NKTR NEKTAR THERAPEUTICS -- $56,071.40 4,634
0.03% SHC SOTERA HEALTH CO -- $54,117.12 2,487
0.03% ONEM 1LIFE HEALTHCARE INC -- $51,838.08 4,263
0.03% AGIO AGIOS PHARMACEUTICALS INC -- $45,202.96 1,364
0.03% GDRX GOODRX HOLDINGS INC-CLASS A -- $43,255.35 1,611
0.03% CVET COVETRUS INC -- $42,220.65 2,595
0.02% BBIO BRIDGEBIO PHARMA INC -- $34,412.25 2,699
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $24,740.64 1,863
0.01% AGL AGILON HEALTH INC -- $23,277.07 1,187
0.01% AMWL AMERICAN WELL CORP-CLASS A -- $22,800.96 4,914
0.01% BLI BERKELEY LIGHTS INC -- $10,114.82 1,046
-- SGFY SIGNIFY HEALTH INC -CLASS A -- $7,762.04 598
-- -- DJ U.S. HEALTH CARE INDEX SWAP BANK OF AMERICA NA 13,402,392 -- 9,262
-- -- DJ U.S. HEALTH CARE INDEX SWAP CITIBANK NA 34,746,084 -- 24,012
-- -- DJ U.S. HEALTH CARE INDEX SWAP GOLDMAN SACHS INTERNATIONAL 40,207,176 -- 27,786
-- -- DJ U.S. HEALTH CARE INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 512,249 -- 354
-- -- DJ U.S. HEALTH CARE INDEX SWAP SOCIETE GENERALE 47,886,564 -- 33,093
-- -- DJ U.S. HEALTH CARE INDEX SWAP UBS AG 37,781,953 -- 26,110

Index

as of 9/30/2021

  • Total Number of Companies145
  • Price/Earnings Ratio25.311
  • Price/Book Ratio5.133
  • Dividend Yield ( % )1.341
  • Avg. Index Market Capitalization$38.78 billion
About the Index

The Dow Jones U.S. Health Care Index measures the performance of the health care economic sector of the U.S. equity market. Component companies include health care providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series Research & Insights

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This leveraged ProShares ETF seeks a return that is 2x the return of its underlying benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, holding periods of greater than one day can result in returns that are significantly different than the target return, and ProShares' returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. Investors should monitor their holdings as frequently as daily. Investors should consult the prospectus for further details on the calculation of the returns and the risks associated with investing in this product.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Dow Jones U.S. Health Care IndexSM" is a product of Dow Jones Indexes, the marketing name and a licensed trademark of CME Group Index Services LLC ("CME Indexes"). "Dow Jones,®" "DJ," "Dow Jones Indexes" and "Dow Jones U.S. Health Care Index" are service marks of Dow Jones Trademark Holdings, LLC ("Dow Jones") and have been licensed to CME Indexes and sublicensed to ProShares. ProShares have not been passed on by CME Indexes or Dow Jones as to their legality or suitability. ProShares based on the Dow Jones U.S. Health Care Index are not sponsored, endorsed, sold or promoted by CME Indexes or Dow Jones, and they make no representation regarding the advisability of investing in ProShares. THESE ENTITIES AND THEIR AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares ETFs (ProShares Trust and ProShares Trust II) are distributed by SEI Investments Distribution Co., which is not affiliated with the funds' advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.